Research has found improving the function of the gut microbiome may delay the onset of type 1 diabetes (T1D). Professor Emma Hamilton-Williams of The University of Queensland, from the Frazer Institute said 21 individuals with T1D were given an oral biotherapy containing short chain fatty acids (SCFA), which are metabolites usually produced by gut bacteria […]
Read More… from Gut microbiome could delay onset of type 1 diabetes